Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients-Reference-Cited by-同舟云学术

Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients

Published:2011-03-01 Issue:1 Volume:127 Page:163-170
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Hutteman Merlijn,Mieog J. Sven D.,van der Vorst Joost R.,Liefers Gerrit Jan,Putter Hein,Löwik Clemens W. G. M.,Frangioni John V.,van de Velde Cornelis J. H.,Vahrmeijer Alexander L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1419-0.pdf

Reference20 articles.

1. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–651

2. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203–208

3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP, Wolmark N (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888

4. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del BP, Renier M, Racano C, Carraro P, Nitti D (2008) A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207–213

5. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981–22023 AMAROS Trial. Ann Surg Oncol 17:1854–1861

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of methylene blue combined with indocyanine green in sentinel lymph node metastasis in breast cancer: a prospective pilot cohort study;2024-04-17

2. Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives;Journal of Nanobiotechnology;2024-03-29

3. Carbon nanoparticles versus patent blue dye for detection of sentinel lymph node in patients with early breast cancer;The Egyptian Journal of Surgery;2024-03-22

4. Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery;European Journal of Surgical Oncology;2024-02

5. Size-Dependent Effect of Indocyanine Green Nanoimaging Agent for Metastatic Lymph Node Detection;Biomaterials Research;2024-01